Skip to content
  • Sunday, 26 July 2026
  • 2:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
Neuroscience & Brain Research

Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find

Rifan Muazin Jul 6, 2026 0

A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study

Rifan Muazin Jun 29, 2026 0

A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 31, 2026 0

Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 20, 2026 0

Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 13, 2026 0

In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 5, 2026 0

Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Linked to Significant Increase in Parkinson’s Disease Risk According to New UCLA Health Study

Rifan Muazin Apr 5, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Increases Parkinson’s Disease Risk by Over Two and a Half Times UCLA Health Study Finds

Rifan Muazin Mar 27, 2026 0

A groundbreaking longitudinal study conducted by researchers at UCLA Health has established a definitive link between chronic residential exposure to…

Read More
Neuroscience & Brain Research

UCLA and UCSF Researchers Uncover Genetic Mechanisms Behind Neuronal Resistance to Tau Protein Buildup in Alzheimer’s Disease

Rifan Muazin Mar 23, 2026 0

The landscape of neurodegenerative research has been significantly altered by a collaborative breakthrough from scientists at UCLA Health and the…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Chlorpyrifos Linked to Significantly Higher Risk of Parkinson’s Disease According to UCLA Health Study

Rifan Muazin Mar 19, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.AvenCell Therapeutics Unveils Promising Early Data for Switchable Allogeneic CAR-T Therapy in Relapsed/Refractory AML at EHA 2026Yale Researchers Unveil Molecular Mechanism Behind Sperm-Egg Interaction Blocking with Implications for Infertility and ContraceptionProfessor Albert Heck Honored with John B. Fenn Award for Transformative Contributions to Biomolecular Mass Spectrometry
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ